# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-22-000705
Filing Date
2022-04-11
Accepted
2022-04-11 17:14:56
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | e3691_defa14a.htm | DEFA14A | 18940
2 | GRAPHIC | img_001.jpg | GRAPHIC | 427014
3 | GRAPHIC | img_002.jpg | GRAPHIC | 426063
| Complete submission text file | 0001731122-22-000705.txt |  | 1195046

Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 22820378
SIC: 2836 Biological Products, (No Diagnostic Substances)